|
|
宏基因组学在感染性疾病诊治中的研究进展 |
王硕, 张志华 |
承德医学院附属医院血液内科, 河北 承德 067000 |
|
[1] Piantadosi A,Kanjilal S,Ganesh V,et al.Rapid detection of powassan virus in a patient with encephalitis by metagenomic sequencing[J].Clinical Infection Disease,2018,66(5):789~792. [2] Schlaberg R,Chiu CY,Miller S,et al.Validation of metagenomic next-generation sequencing tests for universal pathogen detection[J].Arch Pathol Lab Med,2017,141(6):776~786. [3] Samarkos M,Mastrogianni E,Kampouropoulou O.The role of gut microbiota in clostridium difficile infection[J].European Journal Of Internal Medicine,2018,50:28~32. [4] Deurenberg RH,Bathoorn E,Chlebowicz MA.Application of next generation sequencing in clinical microbiology and infection prevention[J].Journal of Biotechnology,2017,243:16~24. [5] Van NE,Vrieze A,Nieuwdorp M.Duodenal infusion of donor feces for recurrent clostridium difficile[J].New England Journal of Medicine,2013,368(5):407~415. [6] Langelier C,Kalantar KL,Moazed F.Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults[J].Proc Natl Acad Sci USA,2018,115(52):E12353~E12362. [7] Wang Z,Gerstein M,Snyder M,et al.RNA-Seq:a revolutionary tool for transcriptomics[J].Nature Reviews Genetics,2009,10(1):57~63. [8] Boulange CL,Neves AL,Chilloux J et al.Impact of the gut microbiota on inflammation,obesity,and metabolic disease[J].Genome Med,2016,8(1):42. [9] Hidewaki N,Masashi F.Whole genome sequencing analysis for cancer genomics and precision medicine[J].Cancer Science,2018,109(3):513~522. [10] Zaas AK,Aziz H,Lucas J,et al.Blood gene expression signatures predict invasive candidiasis[J].Science Translational Medicine,2010,2(1):21. [11] Zak DE,Penn NA,Scriba TJ,et al.A blood RNA signature for tuberculosis disease risk:a prospective cohort study[J].Lancet,2016,387(10035):2312~2322. [12] Zhang YH,HuangT,Chen L,et al.Identifying and analyzing different cancer subtypes using RNA-seq data of blood platelets[J].Oncotarget,2017,8(50):87494~87511. [13] Allegretti M, Fabi A, Buglioni S, Martayan A et al.Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations[J].Exp Clin Cancer Res,2018,37(1):47. [14] Kanwal F, Kramer J,Asch SM.Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents[J].Gastroenterology,2017,13(4):996~1005. |
|
|
|